K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials
- 11 January 2007
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (2), 265-266
- https://doi.org/10.1097/qad.0b013e32801199ee
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Resistance development over 144 weeks in treatment‐naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903*HIV Medicine, 2006
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in AfricaAIDS, 2006
- HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell cultureAIDS, 2006